Search results
Results from the WOW.Com Content Network
In July 2011, Valeant acquired Ortho Dermatologics from Janssen Pharmaceuticals for $345 million. The acquisition included the products Retin-A Micro, Ertaczo, and Renova, also known as tretinoin. [24] In August 2011, Valeant acquired 87.2% of the outstanding shares of Sanitas Group for €314 million. [25]
From 1995 to 2003, Ortho marketed the ParaGard copper T-380A IUD in the United States. In 2001, Ortho introduced the Ortho Evra transdermal contraceptive patch in the United States. In 1993, Ortho Pharmaceutical merged with McNeil Pharmaceutical in 1993 to form Ortho-McNeil Pharmaceutical. In Canada, Ortho Products began operations in Montreal ...
C 13 H 15 N 3 O 3: Molar mass: 261.281 g·mol −1 Density: 1,34 Melting point: 169-171 ... Imazapyr is an ingredient of the commercial product Ortho GroundClear.
Norelgestromin/ethinylestradiol, sold under the brand name Ortho Evra among others, is a contraceptive patch containing the progestin norelgestromin and the estrogen ...
Ortho-McNeil was found liable in two 2013 civil suits by women who gave birth to children with birth defects after taking Topamax while pregnant. The jury found that they negligently failed to warn the patients and their doctors of the risks associated with Topamax when used by patients during pregnancy. [ 5 ]
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
o-Toluidine (ortho-toluidine) is an organic compound with the chemical formula CH 3 C 6 H 4 NH 2. It is the most important of the three isomeric toluidines. It is a colorless liquid although commercial samples are often yellowish. It is a precursor to the herbicides metolachlor and acetochlor. [2]
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide. [3]On May 8, 2020 the U.S. Food and Drug Administration (FDA) issued to Quidel the first emergency use authorization (EUA) for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic.